8
Efficacy of leaf extracts of Vernonia amygdalina Del. from central Africa on atopic eczema
Authors: Nlandu Roger Ngatu, Ryoji Hirota, Maiko Kaneko Okajima, Luzitu Severin Nangana, Basilua Andre Muzembo, Masamitsu Eitoku, Okitotsho Stanislas Wembonyama, Tatsuo Kaneko Benjamin Longo-Mbenza and Narufumi Suganuma
Number of views: 446
Abs
tract
Vernonia amygdal
ina
Del. is an edible plant which is a member of the Asteracaea family, genus
Vernonia, growing in the tropical Africa, whose leaf extracts are used as a remedy for malaria,
cough, gastrointestinal disorders and hepatitis , whereas both root and leaf extracts are used to
treat fever, hiccups, kidney disease, diabetes and helminthiasis in African ethnomedicine. The
plant extracts are reported to contain antioxidant flavonoid compounds(Luteolin, Luteolin 7-O-
b-glucoroniside, Luteolin 7-O-b-glucoside) and saponins such as Vernoniosides A1, A2, A3, B1,
B2, D3 and C. T heir ma in active sesquiterpenes areVernodalin, Vernodalol, Vernolepin and
Vernomygdin and Vernolides. We report on the safety and efficacy of the water and alcoholic
extracts of
Vernonia amygdalina
leaf in children with atopic eczema.In this preliminary clinical
trial, 25 atopic eczema or atopic dermatitis (AD) school children (age: 5-17 y) who satisfied
entry criteria and completed at least 2 weeks of treatment were considered in this study. Each
patient was randomly assigned one of the following topical treatments: water (Vamex1) and
ethanol extract s (Vamex2) of
V. amygdalina
leaf, dexamethasone or Vaseline (5 -7 patients/
group). Clinical assessment and the evaluation of disease severity were performed once a week
using the Eczema Area Severity Index (EASI) scoring system. The treatment was administered
topically twice daily; hematological assays and hepatic function assessments were performed.
Topical application of Vamex1, Vamex2, as well as dexamethasone, significantly reduced the
disease severity (EASI score) (vs. Vaseline; p<0.05); though dexamethasone showed a relatively
better effect as compared to Vamex1 and Vamex2, the difference did not reach the significance
level. In addition, topical Vamex1 and Vamex2 relieved itch within the second week of treatment
(vs. Vaseline; p<0.05). Results from the hematological and immunological assays showed a
significant reduction in ESR in Vamex1, Vamex2 and dexamethasone-treated patients (vs. Vaseline;
p<0.05), whereas serum transaminases (AST, ALT ) remained within normal ranges in all groups
after a four-week treatment period. In addition, a decrease in total IgE was noted in dexamethasone
and Vamex-treated patients, but not significantly. No side effects related to any of the treatments
was noted.Results from this preliminary trial show that topical application of
Vernonia amygdalina
leaf extracts might be safer and has a potential to serve as natural alternative remedy for mild to
moderate atopic dermatitis